These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 35048560)

  • 1. The Intracellular and Extracellular Microenvironment of Tumor Site: The Trigger of Stimuli-Responsive Drug Delivery Systems.
    Jing X; Hu H; Sun Y; Yu B; Cong H; Shen Y
    Small Methods; 2022 Mar; 6(3):e2101437. PubMed ID: 35048560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimuli-responsive drug delivery systems for head and neck cancer therapy.
    Liang J; Yang B; Zhou X; Han Q; Zou J; Cheng L
    Drug Deliv; 2021 Dec; 28(1):272-284. PubMed ID: 33501883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface-anchored tumor microenvironment-responsive protein nanogel-platelet system for cytosolic delivery of therapeutic protein in the post-surgical cancer treatment.
    Fan X; Wang K; Lu Q; Lu Y; Liu F; Li L; Li S; Ye H; Zhao J; Cao L; Zhang H; He Z; Sun J
    Acta Biomater; 2022 Dec; 154():412-423. PubMed ID: 36280028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polysaccharide-based tumor microenvironment-responsive drug delivery systems for cancer therapy.
    Wu Q; Hu Y; Yu B; Hu H; Xu FJ
    J Control Release; 2023 Oct; 362():19-43. PubMed ID: 37579973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasound-mediated nano drug delivery for treating cancer: Fundamental physics to future directions.
    Moradi Kashkooli F; Jakhmola A; Hornsby TK; Tavakkoli JJ; Kolios MC
    J Control Release; 2023 Mar; 355():552-578. PubMed ID: 36773959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Redox dual-stimuli responsive drug delivery systems for improving tumor-targeting ability and reducing adverse side effects.
    Li R; Peng F; Cai J; Yang D; Zhang P
    Asian J Pharm Sci; 2020 May; 15(3):311-325. PubMed ID: 32636949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in Multiple Stimuli-Responsive Drug-Delivery Systems for Cancer Therapy.
    Jia R; Teng L; Gao L; Su T; Fu L; Qiu Z; Bi Y
    Int J Nanomedicine; 2021; 16():1525-1551. PubMed ID: 33658782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor microenvironment-induced structure changing drug/gene delivery system for overcoming delivery-associated challenges.
    Zhang M; Guo X; Wang M; Liu K
    J Control Release; 2020 Jul; 323():203-224. PubMed ID: 32320817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimuli-responsive drug delivery systems triggered by intracellular or subcellular microenvironments.
    Sun T; Jiang C
    Adv Drug Deliv Rev; 2023 May; 196():114773. PubMed ID: 36906230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimuli-responsive nanoassemblies for targeted delivery against tumor and its microenvironment.
    Sia CS; Lim HP; Tey BT; Goh BH; Low LE
    Biochim Biophys Acta Rev Cancer; 2022 Sep; 1877(5):188779. PubMed ID: 35977690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor Microenvironment Sensitive Nanocarriers for Bioimaging and Therapeutics.
    Park H; Saravanakumar G; Kim J; Lim J; Kim WJ
    Adv Healthc Mater; 2021 Mar; 10(5):e2000834. PubMed ID: 33073497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploiting a New Approach to Destroy the Barrier of Tumor Microenvironment: Nano-Architecture Delivery Systems.
    Sun Y; Li Y; Shi S; Dong C
    Molecules; 2021 May; 26(9):. PubMed ID: 34062992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overcoming the biological barriers in the tumor microenvironment for improving drug delivery and efficacy.
    Zhou Y; Chen X; Cao J; Gao H
    J Mater Chem B; 2020 Aug; 8(31):6765-6781. PubMed ID: 32315375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Multistage Drug Delivery Systems Based on the Tumor Microenvironment.
    Chen B; Dai W; He B; Zhang H; Wang X; Wang Y; Zhang Q
    Theranostics; 2017; 7(3):538-558. PubMed ID: 28255348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and application of pH-responsive drug delivery systems.
    Ding H; Tan P; Fu S; Tian X; Zhang H; Ma X; Gu Z; Luo K
    J Control Release; 2022 Aug; 348():206-238. PubMed ID: 35660634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticancer nanomedicines harnessing tumor microenvironmental components.
    Li Y; Chen Z; Gu L; Duan Z; Pan D; Xu Z; Gong Q; Li Y; Zhu H; Luo K
    Expert Opin Drug Deliv; 2022 Apr; 19(4):337-354. PubMed ID: 35244503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smart Nanoplatforms Responding to the Tumor Microenvironment for Precise Drug Delivery in Cancer Therapy.
    Wang Y; Deng T; Liu X; Fang X; Mo Y; Xie N; Nie G; Zhang B; Fan X
    Int J Nanomedicine; 2024; 19():6253-6277. PubMed ID: 38911497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redox-responsive nano-carriers as tumor-targeted drug delivery systems.
    Raza A; Hayat U; Rasheed T; Bilal M; Iqbal HMN
    Eur J Med Chem; 2018 Sep; 157():705-715. PubMed ID: 30138802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimuli-Responsive Polymer-Based Nanosystems for Cancer Theranostics.
    Wei D; Sun Y; Zhu H; Fu Q
    ACS Nano; 2023 Dec; 17(23):23223-23261. PubMed ID: 38041800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biopolymer-based tumor microenvironment-responsive nanomedicine for targeted cancer therapy.
    Jha A; Kumar M; Bharti K; Manjit M; Mishra B
    Nanomedicine (Lond); 2024 Mar; 19(7):633-651. PubMed ID: 38445583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.